Literature DB >> 6810737

The new beta-lactamase-stable cephalosporins.

H C Neu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810737     DOI: 10.7326/0003-4819-97-3-408

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  85 in total

1.  Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

Authors:  C E Smith; B S Tillman; A W Howell; R N Longfield; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.

Authors:  J C Engle; P W Lifland; C J Schleupner
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

3.  A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.

Authors:  P H Karakusis; G M Trenholme; S Levin
Journal:  Infection       Date:  1985       Impact factor: 3.553

4.  Clinical superinfection and its attendant symptomatic changes in pediatrics.

Authors:  K Sunakawa; H Akita; S Iwata; Y Sato
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Cefotaxime in pneumococcal meningitis.

Authors:  H Lecour; A Seara; A M Miranda; J Cordeiro
Journal:  Infection       Date:  1985       Impact factor: 3.553

6.  Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.

Authors:  C J Schleupner
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.

Authors:  R L Baker; R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Cefsulodin sodium therapy in cystic fibrosis patients.

Authors:  I Cabezudo; R L Thompson; R F Selden; S H Guenthner; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

9.  Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.

Authors:  Fred C Tenover; Patti M Raney; Portia P Williams; J Kamile Rasheed; James W Biddle; Antonio Oliver; Scott K Fridkin; Laura Jevitt; John E McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 10.  Treatment of bacterial meningitis.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.